Replies to post #19483 on BioAdaptives Inc (BDPT)

[powerbattles]

"During July and early August, The REG A filed and as amended in November 2022 for 200,000,000 common shares at $0.001 were fully subscribed. This provides the Company with the liquidity to pursue further research into its lead products: Pluripain® , SleepEZ™ and Primilungs™ and move the Company’s testing, development and marketing programs forward. The Company is also in discussion with marketing specialists in expanding its footprint on the Amazon market place now that the RegA has been fully subscribed and provide the necessary funding for more intensive marketing efforts. Since the appointment of FCBTherapy as its exclusive Distributor, LiveStock impact is withdrawing from its own websale and is encouraged with the first initial wholesale order from FCBTherapy is over $9000 which is double the last 6 months gross sales."

You understand that, yes? They got a HUGE wholesale order of $9,000 for their equine products. And that was DOUBLE what they made in the past 6 months! How this company has a market cap over $50,000 is the true mystery.

Let's try this. You seem very wise and experienced habitually criticizing with intentionally introducing false assumptions into your calculations. I am sure you comprehend the keyword first initial wholesale order.

Let's clarify this. The first initial wholesale order was DOUBLE what they made in the past 6 months! Don't you think that is very impressive? What's wrong with that?

Do you grasp the concept now, or are you still finding it confusing? The words you've emphasized highlight in bold suggest that you might not fully grasp the distinction between a non-exclusive license and an exclusive license.

"We are reliant on direct web sales of the nutraceutical lines for humans and the All-in-One animal products for revenues, none of which has produced any significant revenue yet. Because of this, we are now exploring the wholesale and affiliate markets for their sales. We have very limited experience in marketing and have yet to develop reliable sales expectations and forecasting."

Thank you for pointing this out because many people are still unaware of the company's revenue. The quote above indicates that the company in question lacks significant prior experience in marketing products, and they haven't yet established a dependable marketing method. Therefore, they can't accurately estimate their future sales. Marketing is key to any business's success, and they have not yet marketed their product, which is why low revenue is understandable.

You virtually call me out on every post. Do you have a personal issue with me? I prefer not to engage in a conversation with you. Please refrain from replying to my posts.